Sarah Hardy
InvestorInvestor at Archangels
Edinburgh, Scotland
Writes $100K β $5M checks Β· typically $1.5M
Find your path to Sarah
89 people in our graph share verified history with Sarah β schools, employers, funds. One of them is your warm intro.
Yusuf SherwaniunlockedSarah: together at Wellcome Trust (2014)
Γ3Sarah: together at Wellcome Trust
Γ8Sarah: together at University of Aberdeen
About
Experienced in financing early-stage technology companies with a focus on life sciences and healthcare. She joined Archangels in 2016 after roles at Wellcome Trust and Advent Life Sciences, and leads new investments.
Experience
- Archangel Investors LimitedDirector, Head of New Investmentcurrent2020 β presentEdinburgh, Scotland, United Kingdom
- ROSLIN FOUNDATIONTrustee; Non Exec Directorcurrent2022 β present
- Scottish Social Growth FundBoard Member2019 β 2025
- Board memberData Driven Innovation (DDI ) Delivery Board Member2020 β 2024
- Archangels Investors LimitedChief Investment Officer2016 β 2020Greater Edinburgh Area
- The Wellcome TrustSenior Business Analyst2006 β 2016London
- The Wellcome TrustScienfic Programme Officer2001 β 2006
- Advent Venture PartnersAssociate, (secondment)2012London Area, United Kingdom
- Parke-Davis Neuroscience Research Centre, CambridgeResearcher1999 β 2000
Skills & more
Science12Project Management8Due Diligence6Biotechnology22Technology Transfer41Clinical Research4Healthcare3Lifesciences18Contract Negotiation2Molecular Biology3PharmacologyClinical Trials2
+12 more
Clinical DevelopmentBusiness StrategyVenture CapitalOncologyNeuroscienceCommercializationR&DMedical DevicesPharmaceutical IndustryCROStrategyCTMSFrom Sarah's professional profile.
Colleagues at Archangels
Adam Stokes
Academic in Residence at Archangels
Andrew Sealey
Member of the Board at Archangels
Dan McKiddie
Investment Manager at Archangels
David Ovens
Joint Managing Director at Archangels
Eric Young
Investor at Archangels
Ian Macleod
Chair at Archangels
Lindsay Miller
Office Manager at Archangels
Maureen Kinsler
Member of the Board at Archangels
Network2
Investors connected to Sarah in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Sarah Hardy?
- Experienced in financing early-stage technology companies with a focus on life sciences and healthcare. She joined Archangels in 2016 after roles at Wellcome Trust and Advent Life Sciences, and leads new investments.
- Where does Sarah Hardy work?
- Sarah Hardy is Investor at Archangels.
- What check size does Sarah Hardy write?
- Sarah Hardy typically writes checks of $100K β $5M.
- Where did Sarah Hardy go to school?
- Sarah Hardy studied at University of Aberdeen (PhD, Molecular NeuroPharmacology).
Same school
Also attended University of Aberdeen64
Janet WolpertInvestor at Index VenturesChloe ParamattiInvestor at EQT VenturesIsabelle TressonCommunications & Marketing Lead at Partech VenturesWill CadellVenture Advisor at Cultivation CapitalJai TaylorInvestor at Blue Wire CapitalJohn CampbellEIR at Delin Ventures
+ 58 more
Shared employers
Also worked at Board member2
Also worked at The Wellcome Trust14
Yusuf SherwaniCo-Founder and CEO at Pelago; a Londoner living in New York CityMohadeseh AbdullahiPartner at Giant Ventures Global LlpCharles SpicerNon-Executive Chair at EMV CapitalAlex GwytherInvestment Director at Mercia VenturesTim HainesExecutive Partner at AbingworthFreddie DearPrincipal at Monograph Capital Partners
+ 8 more


























